These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15826712)

  • 21. [Immune status of patients with different outcomes of acute hepatitis C].
    Iushchuk ND; Dudina KR; Znoĭko OO; Mal'kov IG; Kuzina LE; Cheshik DS; Isaguliants MG
    Ter Arkh; 2005; 77(11):32-7. PubMed ID: 16404859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
    Quiroga JA; Castillo I; Llorente S; Bartolomé J; Barril G; Carreño V
    J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies detectable by third-generation enzyme immunoassay.
    Hadlich E; Alvares-Da-Silva MR; Dal Molin RK; Zenker R; Goldani LZ
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1506-9. PubMed ID: 17716354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
    Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
    Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
    Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung MC; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
    Z Gastroenterol; 2009 Jun; 47(6):531-40. PubMed ID: 19533544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection.
    Sagnelli E; Tonziello G; Pisaturo M; Sagnelli C; Coppola N
    Antivir Ther; 2012; 17(7 Pt B):1453-8. PubMed ID: 23322703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection.
    Wang CC; Morishima C; Chung M; Engelberg R; Krantz E; Krows M; Sullivan DG; Gretch DR; Corey L
    J Infect Dis; 2006 Mar; 193(5):672-6. PubMed ID: 16453262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-specific antibody titres in different phases of hepatitis C virus infection.
    Nikolaeva LI; Blokhina NP; Tsurikova NN; Voronkova NV; Miminoshvili MI; Braginsky DM; Yastrebova ON; Booynitskaya OB; Isaeva OV; Michailov MI; Archakov AI
    J Viral Hepat; 2002 Nov; 9(6):429-37. PubMed ID: 12431205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Kao JH; Lai MY; Chen PJ; Chen DS
    J Formos Med Assoc; 1997 Oct; 96(10):825-8. PubMed ID: 9343983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.